金融界9月23日消息，华润医疗表示，公司已遵循上市规则，形成良好的公司治理，并确保符合相关法律和法规的要求。公司的审计委员会已审查了未经审核的2024年中期财务报告，并认为报告根据相关会计准则和法律要求进行编制，公司透明公开地披露了这些信息。然而，以上数据未经审核。此外，董事会在报告期内对公司的风险管理和内部控制系统效率进行了评估，并将根据公司业务的发展进行优化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.